Our notion, that CK18 upregulation reflects aberrant differentiation or dedifferentiation in these cancers is supported by significant associations of elevated CK18 protein levels with high pT stage and presence of nodal metastasis that could be identified in a combined analysis of our 230 squamous cell carcinomas with available clinico-pathological data. This evidence concerns the gene KRT18 and squamous cell carcinoma.